GlobalData on MSN2d
Nevro secures CE mark for AI-based spinal cord stimulation system
US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...
MassDevice3d
Nevro wins CE mark for HFX iQ spinal cord stim for pain relief
Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.
Time16d
Reducing Chronic Pain
Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...
clinicalpainadvisor.com14d
High-Frequency Spinal Cord Stimulation Yields Benefits in Diabetic Neuropathy
Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.
PharmiWeb8d
Global Spinal Cord Stimulators Market Set for Remarkable Growth, Expected to Reach USD 5,441.4 Million by 2033
The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...